Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol for Diabetic Peripheral Neuropathy
NCT06201611Phase 3Recruiting
- Sponsor
- St. John's Research Institute
- Start
- Nov 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nebivolol in diabetic peripheral neuropathy (DPN), sponsored by St. John's Research Institute. Started Nov 2024; status: recruiting.
02
Drugs
nebivolol
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT06201611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06201611.